Continuous Anlotinib Combined with Oral Vinorelbine has Shown Anti-Tumor Efficiency in Refractory HER2 Negative Advanced Breast Cancer
Jia-Yi Huang,1,* Yan Zhang,2,* Cai-Wen Du1 1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdo...
Saved in:
| Main Authors: | Huang JY, Zhang Y, Du CW |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-06-01
|
| Series: | Breast Cancer: Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/continuous-anlotinib-combined-with-oral-vinorelbine-has-shown-anti-tum-peer-reviewed-fulltext-article-BCTT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vinorelbine With or Without Thiotepa for HER2‐Negative Metastatic Breast Cancer: A Propensity Score Analysis
by: Aurelia Robert, et al.
Published: (2025-08-01) -
Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
by: Devleena, et al.
Published: (2010-03-01) -
Dynamic Evaluation of Vinorelbine-Induced Phlebitis of Dorsalis Pedis Vein in a Rat Model
by: JIANG Meng, et al.
Published: (2025-06-01) -
Pharmacoeconomic aspects of oral vinorelbine application: a budget impact analysis considering the new registered price
by: D. A. Ivanov, et al.
Published: (2021-07-01) -
Efficacy and safety of anlotinib monotherapy or combination therapy in the treatment of patients with advanced non-small cell lung cancer: a retrospective real-world study conducted in East China
by: Jia Wei, et al.
Published: (2025-04-01)